Showing results (31-40 of 74) with videos related to
Sort By:
Pageof 8
Canadian Journal of Kidney Health and Disease|March 28, 2018
An Examination of the Application of the Kidney Donor Risk Index in British ColumbiaCaren Rose, Yvonne Sun, Ed Ferre, et al.Canadian Journal of Kidney Health and Disease|December 6, 2021
Compatible Donor and Recipient Pairs' Perspectives on Participation in Kidney Paired Donation Programs: A Mixed-Methods StudyMarie-Chantal Fortin, John Gill, Julie Allard, et al.Transplantation|February 20, 2015
Willingness of Directed Living Donors and Their Recipients to Participate in Kidney Paired Donation ProgramsElizabeth Hendren, Jagbir Gill, David Landsberg, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 10, 2012
Incidence and consequences of acute kidney injury in kidney transplant recipientsAnita Mehrotra, Caren Rose, Neesh Pannu, et al.Transplantation|October 20, 2015
Estimation of Potential Deceased Organ Donors in CanadaCaren Rose, Peter Nickerson, Francis Delmonico, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 26, 2008
Outcomes of kidney transplantation from older living donors to older recipientsJagbir Gill, Suphamai Bunnapradist, Gabriel M Danovitch, et al.BMC Nephrology|March 22, 2017
Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort studyHolly L Hutton, Adeera Levin, Jagbir Gill, et al.Clinical Kidney Journal|April 11, 2015
The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologistsSean Barbour, Monica Beaulieu, Jagbir Gill, et al.Journal of the American Society of Nephrology : JASN|March 10, 2018
The Change in Living Kidney Donation in Women and Men in the United States (2005-2015): A Population-Based AnalysisJagbir Gill, Yayuk Joffres, Caren Rose, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2017
The population-level costs of immunosuppression medications for the treatment of glomerulonephritis are increasing over time due to changing patterns of practiceSean Barbour, Clifford Lo, Gabriela Espino-Hernandez, et al.Pageof 8